Latest News
-
LIC New Jeevan Shanti 858 Plan: How To Earn Rs 10,000 Pension Per Month After Retirement? Check Eligibility! -
Kronox Lab Sciences Granted SEBI Approval to Initiate IPO -
Big News For F&O Traders! NSE To Launch Derivatives On Nifty Next 50 From April 24; Key Highlights! -
Aadhaar POI, POA Update: How To Submit Your Updated Identity, Address Proof Documents Online? -
Infosys Q4 Profit Surges 30% to Rs 7,969 Crore, Eyes Future Growth -
China Offloads $22.7 Billion in US Treasury Amid Growing Tensions -
7:1 Bonus, Rs 778.75/Sh Dividend In 20 Yrs: Infosys To Offer Massive Rewards, Up Next Rs 28/Sh Payout Soon -
1:1 Bonus, 16.50/Share Dividend: NBFC To Recommend Dividend, Buy For TP Rs 900: Motilal Oswal -
Infosys Q4 Results: Cons PAT Shoots Up 30% YoY To Rs 7,975 Crore; FY25 Guidance Here -
Gold Prices In US: Yellow Metal Rates Propel To Record Highs Amidst Escalating Middle East Tensions
Anupam Rasayan Files For Rs. 760 Crore IPO With SEBI
To tap the current market momentum, another speciality chemicals company Anupam Rasayan has filed its draft red herring prospectus (DRHP) with the SEBI to float a Rs. 760 crore IPO.
The proceeds from the public issue shall be primarily deployed for repayment of debt. Further the company has taken a decision to reserve some portion of the public issue for its employees and may even offer discount to eligible staff.
Also, the company after discussion with the book running lead managers may mull an additional issuance of equity shares, including via private placement method of Rs. 100 crore before filing the DRHP. Axis Capital, Ambit, IIFL Securities and JM Financial are the lead managers to the issue.
Anupam Rasayan, set up in the year 1984 is a Gujarat based company that offers conventional products and has now evolved into custom synthesis and production of life sciences-related specialty chemicals and other specialty chemicals. The company has two separate business divisions namely life sciences specialty chemicals and other specialty chemicals.
GoodReturns.in
